Zymogenet Inc.; Clinical pharmacokinetics of TNF antagonists reviewed
Zymogenet Inc.; Clinical pharmacokinetics of TNF antagonists reviewed
About this item
Full title
Zymogenet Inc.; Clinical pharmacokinetics of TNF antagonists reviewed
Publisher
Atlanta: NewsRx
Journal title
Biotech Week, 2005, p.1570
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
"Within the causal chain of events after a drug is administered, the exposure (or PK) precedes the effect (or PD)," stated [Ivan Nestorov]. "Therefore, whenever any differentiation in the beneficial and/or adverse effects between drugs with similar mechanisms of action is observed, the underlying clinical PK is among the first considerations.
Alternative Titles
Full title
Zymogenet Inc.; Clinical pharmacokinetics of TNF antagonists reviewed
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_205669179
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_205669179
Other Identifiers
ISSN
1535-2757
E-ISSN
1537-1395
How to access this item
Log in as a Library member
